Respiratory control and ADP-to-O ratios
| . | Lean . | Obese . |
|---|---|---|
| RCR | ||
| P + M | 20.5 ± 1.8 | 17.4 ± 1.3 |
| PC + M | 9.1 ± 1.6 | 11.4 ± 1.7 |
| P + M + GLU | 12.9 ± 2.4 | 14.1 ± 1.4 |
| GLU + MAL | 16.1 ± 1.4 | 13.7 ± 2.3 |
| P + M + GLU + SUCC | 10.0 ± 0.6 | 10.7 ± 1.2 |
| ADP/O | ||
| P + M | 2.30 ± 0.03 | 2.26 ± 0.05 |
| PC + M | 1.94 ± 0.05 | 1.88 ± 0.06 |
| P + M+ GLU | 2.14 ± 0.06 | 2.03 ± 0.06 |
| GLU + MAL | 2.12 ± 0.08 | 2.02 ± 0.07 |
| P + M + GLU + SUCC | 1.77 ± 0.07 | 1.65 ± 0.03 |
| . | Lean . | Obese . |
|---|---|---|
| RCR | ||
| P + M | 20.5 ± 1.8 | 17.4 ± 1.3 |
| PC + M | 9.1 ± 1.6 | 11.4 ± 1.7 |
| P + M + GLU | 12.9 ± 2.4 | 14.1 ± 1.4 |
| GLU + MAL | 16.1 ± 1.4 | 13.7 ± 2.3 |
| P + M + GLU + SUCC | 10.0 ± 0.6 | 10.7 ± 1.2 |
| ADP/O | ||
| P + M | 2.30 ± 0.03 | 2.26 ± 0.05 |
| PC + M | 1.94 ± 0.05 | 1.88 ± 0.06 |
| P + M+ GLU | 2.14 ± 0.06 | 2.03 ± 0.06 |
| GLU + MAL | 2.12 ± 0.08 | 2.02 ± 0.07 |
| P + M + GLU + SUCC | 1.77 ± 0.07 | 1.65 ± 0.03 |
Data are presented as means ± SE. Lean/obese n: pyruvate (P) plus malate (M), 18/12; palmitoyl-dl-carnitine (PC) plus malate, 16/10; pyruvate plus malate plus glutamate (G), 5/11; glutamate plus malate, 7/5; pyruvate plus malate plus glutamate plus succinate (Succ), 7/7.